Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Boehringer Ingelheim
BioNTech SE
Hoffmann-La Roche
M.D. Anderson Cancer Center
University of Chicago
Monte Rosa Therapeutics, Inc
Amgen
Debiopharm International SA
Daiichi Sankyo
Boehringer Ingelheim
Hoffmann-La Roche
Jonsson Comprehensive Cancer Center
Washington University School of Medicine
AstraZeneca
Boundless Bio, Inc.
ImmunityBio, Inc.
Shanghai Henlius Biotech
H. Lee Moffitt Cancer Center and Research Institute
Boehringer Ingelheim
Amgen
Amgen
Ohio State University Comprehensive Cancer Center
Amgen
M.D. Anderson Cancer Center
AstraZeneca
Case Comprehensive Cancer Center
AstraZeneca
Amgen
National Cancer Institute (NCI)
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)
Washington University School of Medicine
AstraZeneca
AbbVie
National Cancer Institute (NCI)
Bristol-Myers Squibb
Swiss Cancer Institute
Tufts University
National Cancer Institute (NCI)
Advenchen Laboratories, LLC
Merck Sharp & Dohme LLC
Bristol-Myers Squibb
Trans Tasman Radiation Oncology Group
Shanghai Chest Hospital
Medicine Invention Design, Inc